http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2377849-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate | 2008-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_897b45846e78f4a3f45d812330adb47d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8268630c6f041daf5b3c4f3ddefdff58 |
| publicationDate | 2012-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2377849-T3 |
| titleOfInvention | Amino-heterocyclic compounds |
| abstract | A compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein: R is selected from the group consisting of (C1-C6) alkyl, (C2-C6) alkenyl, (C2-C6) alkynyl, cycloalkyl (C3-C8), heterocycloalkyl, aryl and heteroaryl, each of which may be optionally substituted with one to three substituents, the substituents independently selected from the group consisting of (C1-C4) alkyl, (C1-C4) alkoxy, halo and haloalkyl (C1-C4); R1 is selected from the group consisting of hydrogen, (C1-C4) alkyl, (C2-C4) alkenyl, (C2-C4) alkynyl, halo (C1-C4) alkyl and cyclopropyl; R2 is selected from the group consisting of (C1-C6) alkyl, (C2-C6) alkenyl, (C2-C6) alkynyl, (C1-C6) haloalkyl, heteroaryl selected from the group consisting of pyridinyl, pyridazinyl, pyrimidinyl and pyrazinyl , and ER5, wherein the heteroaryl may be optionally substituted with one to three substituents independently selected from the group consisting of (C1-C4) alkyl and halo (C1-C4) alkyl; R3 is selected from the group consisting of hydrogen, (C1-C4) alkyl, (C2-C4) alkenyl, (C2-C4) alkynyl, (C3-C6) cycloalkyl and (C1-C4) haloalkyl; E is selected from the group consisting of -CH2-, -CH2CH2-, -CH2CH2CH2- and -C (O) -; R5 is selected from the group consisting of cycloalkyl (C3-C8), heterocycloalkyl, aryl, aryloxy and heteroaryl, any of which may be optionally substituted with one to three substituents, such substituents being independently selected from the group consisting of (C1 -C4), alkenyl (C2-C4), alkynyl (C2-C4), hydroxyalkyl (C1-C4), haloalkyl (C1-C4), alkoxy (C1-C4), haloalkoxy (C1-C4), cycloalkyl (C3- C8), halo, cyano, phenyl, morpholinyl, (C1-C4) alkyl-amino, pyrazolyl, triazolyl and imidazolyl. |
| priorityDate | 2007-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1605.